Yuflyma, A High Concentration and Citrate-free Adalimumab Biosimilar, Received FDA Approval for Treating Different Forms of Inflammato ry Diseases (Englisch)
Freier Zugriff
- Neue Suche nach: Rajana, Vinod Kumar
- Neue Suche nach: Penumaka, Sudha Madhavi
- Neue Suche nach: Saritha, Cevella
- Neue Suche nach: Ravichandiran, Velayutham
- Neue Suche nach: Mandal, Debabrata
- Neue Suche nach: Rajana, Vinod Kumar
- Neue Suche nach: Penumaka, Sudha Madhavi
- Neue Suche nach: Saritha, Cevella
- Neue Suche nach: Ravichandiran, Velayutham
- Neue Suche nach: Mandal, Debabrata
In:
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
;
22
, 4
;
273-275
;
2023
-
ISSN:
- Aufsatz (Zeitschrift) / Elektronische Ressource
-
Titel:Yuflyma, A High Concentration and Citrate-free Adalimumab Biosimilar, Received FDA Approval for Treating Different Forms of Inflammato ry Diseases
-
Weitere Titelangaben:AIAAMC
-
Beteiligte:Rajana, Vinod Kumar ( Autor:in ) / Penumaka, Sudha Madhavi ( Autor:in ) / Saritha, Cevella ( Autor:in ) / Ravichandiran, Velayutham ( Autor:in ) / Mandal, Debabrata ( Autor:in )
-
Erschienen in:Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry ; 22, 4 ; 273-275
-
Verlag:
- Neue Suche nach: Bentham Science Publishers Ltd.
-
Erscheinungsdatum:01.12.2023
-
Format / Umfang:3 pages
-
ISSN:
-
DOI:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Elektronische Ressource
-
Sprache:Englisch
-
Schlagwörter:
-
Datenquelle:
Inhaltsverzeichnis – Band 22, Ausgabe 4
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 211
-
Enhancing the Antiviral Potential and Anti-inflammatory Properties of Astragalus membranaceus: A Comprehensive ReviewGhabeshi, Soad / Mousavizadeh, Leila / Ghasemi, Sorayya et al. | 2023
- 220
-
An Overview of Antihistamines and their Properties used for Treatment of Different DiseasesChaudhari, Riya / Gosavi, Seema / Bornare, Pratiksha / Sonawane, Saurabh / Ahire, Tejas et al. | 2023
- 230
-
Wound Healing, Anti-inflammatory and Antioxidant Potential of Quercetin Loaded Banana Starch NanoparticlesKumar, Dharmendra / Sharma, Pramod Kumar et al. | 2023
- 236
-
Development of 7H-pyrrolo[2,3-d]pyrimidin-4-amine Derivatives Using QSARINS Tool as BTK Inhibitors for the Treatment of Rheumatoid ArthritisPatil, Shital M. / Asgaonkar, Kalyani. D. / Magdum, Pradnya / Chinde, Vaishnavi / Edake, Aishwarya / Naik, Akshata et al. | 2023
- 250
-
Galectin-3 in Blood Serum and Lymphocytes as a Marker of Myocardial Damage in Patients with Arterial Hypertension and COVID-19Pokrovska, Nataliia / Denysenko, Nataliia / Fomenko, Iryna / Sklyarova, Helen / Basylevych, Andrii / Sklyarov, Eugene / Vari, Sandor G. / Kobylinska, Lesya et al. | 2023
- 261
-
Evaluation of the Capparis Herbacea Willd's Chemistry, Antioxidant and Cytotoxic ActivityTleuberlina, Orynbassar / Mamurova, Asem / Iskakova, Zhanar / Aibuldinov, Yelaman / Kolpek, Ainagul / Kopishev, Yeldar / Satbaeva, Gulbarshyn / Mukazhanova, Zhazira / Kurmanbayeva, Meruyert et al. | 2023
- 273
-
Yuflyma, A High Concentration and Citrate-free Adalimumab Biosimilar, Received FDA Approval for Treating Different Forms of Inflammato ry DiseasesRajana, Vinod Kumar / Penumaka, Sudha Madhavi / Saritha, Cevella / Ravichandiran, Velayutham / Mandal, Debabrata et al. | 2023
- 276
-
Acknowledgements to Reviewers| 2023